<DOC>
	<DOCNO>NCT00536965</DOCNO>
	<brief_summary>A cholesterol/lipid profile screen project high risk patient hyperlipidaemia ( secondary prevention ) already receive cholesterol-lowering therapy . Lipid profile rate patient treat target ( &lt; 100mg/dl patient high risk &lt; 70mg/dl patient high risk ) screen ( office-based specialist ) . The doctor therapy decision screen possible reason decision document . Our aim evaluate dose habit , evaluate many patient treat LDL-C target underline importance treat patient cholesterol target .</brief_summary>
	<brief_title>Percentage Secondary Prevention Patients Treated Their LDL-C Targets</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Carotid Stenosis</mesh_term>
	<criteria>Secondary prevention patient hyperlipidemia atherosclerosis ( coronary heart disease , carotid stenosis , PVD , etc . ) and/or diabetes already receive cholesterollowering therapy Patients receive cholesterollowering therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Hyperlipidemia</keyword>
	<keyword>Need-to-treat</keyword>
	<keyword>NIS</keyword>
	<keyword>Secondary prevention patient hyperlipidemia atherosclerosis ( coronary heart disease , carotid stenosis , PVD , etc . ) and/or diabetes</keyword>
</DOC>